Owner Pfizer Products Inc.

Inventors Maguire, Robert John; Brown, Matthew Frank; Dorff, Peter Hans; Bhattacharya, Samit Kumar; La Greca, Susan Deborah

Agent Shelston IP

Pub. Number AU-A-2007251282

PCT Pub. Number WO2007/132307

Priority 60/799,211 09.05.06 US

Filing date 26 April 2007

Wipo publication date 22 November 2007

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/4439 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

C07D 213/38 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 271/06 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 271/10 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group